Breathtec Provides Update on FAIMS Breathalyzer Development Program (Globe Newswire)
UF startup Breathtec Biomedical Inc. is pleased to report on the development of its Breathtec Disease Detection Breathalyzer prototype (V3) based on... Read More
Nash Pharmaceuticals Announces Positive Pre-Clinical Results Showing Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease (Breathtec Biomedical)
Nash Pharmaceuticals Inc., a wholly owned subsidiary of UF startup Breathtec Biomedical Inc., is pleased to announce that its lead compound for... Read More
Breathtec Provides Nash Pharmaceuticals’ Plans for Next Year (Globe Newswire)
UF startup Breathtec Biomedical Inc. is pleased to provide details on Nash Pharmaceutical’s plans for the next 12 month period. Breathtec recently... Read More
Breathtec to Open New Drug Development Division, Signs LOI to Acquire 100% of Clinical Stage Nash Pharmaceuticals Inc. (Globe Newswire)
UF startup Breathtec Biomedical Inc. is pleased to announce that it will be opening a new drug development division and has signed... Read More
